Back to results
US 9,868,726 B2Granted
Pyridyl benzothiophenes as kinase inhibitors
AssigneeAllergan, Inc.
InventorsSougato Boral, Thomas C. Malone, Shimiao Wang
Life of this patent
Estimating the term…
Abstract
This invention is directed to compounds, which are useful as protein kinase (PK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders, metabolic diseases inflammatory disorders and neurodegenerative disorders.
Claims2
A compound selected from:
- 6-amino-N-[dimethyl(oxido)-λ4-sulfanylidene]-5-{5-[(3-methyl-2-furoyl)amino]-1-benzothien-2-yl}nicotinamide;
- methyl 6-amino-5-{5-[(3-methyl-2-furoyl)amino]-1-benzothien-2-yl}nicotinate;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.